Tesofensine

Name: Tesofensine
Availability: InStock

$110.00

is an investigational once-daily oral medication primarily researched for the treatment of obesity. Originally developed for neurodegenerative conditions like Alzheimer’s and Parkinson’s disease, it was repurposed for weight management after early trials consistently showed significant weight loss as a primary side effect.

Category: Buy PEPTIDES

Description
Reviews (0)

Buy Tesofensine

Tesofensine is an investigational once-daily oral medication primarily researched for the treatment of obesity. Originally developed for neurodegenerative conditions like Alzheimer’s and Parkinson’s disease, it was repurposed for weight management after early trials consistently showed significant weight loss as a primary side effect.

Mechanism of Action

Tesofensine acts as a triple monoamine reuptake inhibitor (SNDRI), affecting the reabsorption of dopamine, serotonin, and norepinephrine in the brain. This mechanism is thought to influence motivation and reduce cravings, increase feelings of fullness, and potentially boost metabolic rate.

Clinical Uses & Efficacy

Weight Loss: Phase 2 trials showed that a 0.5 mg daily dose resulted in approximately 10.6% weight loss over 24 weeks.
Hypothalamic Obesity: A combination of tesofensine and metoprolol, known as Tesomet, has Orphan Drug Designation for this condition.
Alternative to Injections: It is being explored as an oral alternative for patients who prefer pills over weekly GLP-1 injections.
Common Side Effects

Tesofensine has a long half-life, meaning side effects may persist if they occur. Frequent side effects include dry mouth, nausea, constipation, insomnia, headaches, increased alertness, dose-dependent increases in heart rate, and sometimes slight increases in blood pressure. Some users have also reported anxiety or mood swings.

Regulatory Status (Tesofensine)
- USA: Tesofensine is not yet FDA-approved for general use.
- Mexico: A New Drug Application has been submitted to COFEPRIS and received a favorable technical opinion in February 2023, with efforts for market authorization ongoing as of late 2024
- In 2026, the uses for the specialized metabolic and regenerative compounds discussed—Tesofensine, Tesamorelin, TB-500, SLU-PP-332, and Retatrutide—are categorized by their specific physiological targets:
  
  The compounds listed, such as Tesofensine, Tesamorelin, TB-500, SLU-PP-332, and Retatrutide, are a mix of substances that have been researched or used for various purposes related to metabolic function, tissue repair, and cellular processes.
  - Metabolic and Weight Management Compounds: Some of these substances are being investigated for their effects on appetite, metabolism, and fat distribution. This area of research aims to develop treatments for conditions like obesity and metabolic disorders.
  - Tissue Repair and Regeneration: Certain compounds are studied for their potential to promote healing and regeneration of tissues, such as muscles, tendons, and ligaments. This research can be relevant in fields like sports medicine and recovery.
  - Cellular Function and Longevity: Other substances mentioned relate to cellular processes and energy production, which are areas of interest in research related to aging and various health conditions.